Atlas Trials

Instituto Grifols, S.A.

23 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Instituto Grifols, S.A.

RecordFirmDate
Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED). (NCT07264517)Instituto Grifols, S.A.2025-11-03
FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis (NCT04636268)Instituto Grifols, S.A.2023-12-01
Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19 (NCT04495101)Instituto Grifols, S.A.2020-07-29
Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19) (NCT04432324)Instituto Grifols, S.A.2020-06-02
A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19) (NCT04547127)Instituto Grifols, S.A.2020-04-29
Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5% (NCT03702920)Instituto Grifols, S.A.2019-06-17
A Study of Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Haemostasis During Surgery in Paediatric Participants (NCT03461406)Instituto Grifols, S.A.2019-01-18

Track Instituto Grifols, S.A. automatically

Every clearance here is in the API, with alerts when new ones post.